NANOPARTICLE, CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING COMPRISING SAME AND ZWITTERIONIC LIGAND COMPOUND
申请人:Astellas Pharma Inc.
公开号:EP3904331A1
公开(公告)日:2021-11-03
Provided is a novel nanoparticle, a contrast agent for magnetic resonance imaging containing the same, and a zwitterionic ligand compound used in production of the nanoparticle. The contrast agent for MRI of the present invention can be suitably used as a contrast agent for MRI in a medical field. The nanoparticle and the zwitterionic ligand compound of the present invention are applicable to various pharmaceutical compositions and the like, including a contrast agent for MRI, and can be used widely in the fields of pharmaceuticals, biotechnology, and the like, including various diagnosis methods and examination reagents.
本发明提供了一种新型纳米粒子、一种含有该纳米粒子的磁共振成像造影剂以及一种用于生产该纳米粒子的齐聚物配体化合物。本发明的磁共振成像造影剂可适当用作医疗领域的磁共振成像造影剂。本发明的纳米粒子和齐聚物配体化合物适用于包括核磁共振成像造影剂在内的各种药物组合物等,可广泛应用于医药、生物技术等领域,包括各种诊断方法和检查试剂。